Welcome Message
 
Our Company
 
Awards & Recognition
 
Corporate Governance
 
Management Council
Board of Directors
Reports of Insider Transactions
Committee Charters
Corporate Governance Guidelines
Additional Policies and Guidelines
Codes of Conduct
Articles of Incorporation (PDF)
Bylaws (PDF)
 
Corporate Compliance
 
Our Websites
 
Business Links

 

  » BMS.com Home » About Us » Corporate Governance » James M. Cornelius
SEARCH INDEX
 





James M. Cornelius

Chairman and CEO

James M. CorneliusJim Cornelius was elected chairman of the Board by the company’s Board of Directors on February 11, 2008. He was named CEO in September 2006, and he continues serving in that role as well.

“Our vision for Bristol-Myers Squibb is to become a health care leader for the future,” says Jim. “By uniquely combining the best elements of a leading-edge biotech company with the reach and resources of a major pharmaceutical company, we are transforming into a new kind of enterprise – a next-generation BioPharma leader.”

Since 2002 the company has brought nine new products to market for the treatment of serious disease, including two new biologic medicines. “Our focus is helping patients prevail,” says Jim. “Moving forward, our strategy will be unwavering.”

Prior to joining Bristol-Myers Squibb, Jim served as chairman emeritus of the Guidant Board of Directors upon closing of its merger into Boston Scientific in April 2006. He had previously served as chairman and CEO during the merger process and was responsible for the company’s initial public offering and subsequent split-off from Eli Lilly and Company.

Jim was a member of the Board of Directors of Lilly, a member of its Executive Committee and chief financial officer from 1983 to 1995. From 1980-1982, he served as president and CEO of IVAC Corporation, previously a Lilly subsidiary. He continues to serve on the Boards of Given Imaging Ltd. and DIRECTV Group.

Jim has received several honorary doctorate degrees in recognition of his civic and philanthropic activities in Indiana. Jim is president of the Cornelius Family Foundation and has served United Way of Central Indiana in several leadership positions.

Jim’s passion is football. “I’m a Colts fan because they have been so successful on the field. They have one star who gets all the press, but it’s a team effort. I like successful teams – in sports and in business – and our plan for Bristol-Myers Squibb is to be successful, both for our patients and for our stockholders.”

Jim was born in Kalamazoo, Michigan, and attended Michigan State University, where he earned a bachelor’s degree magna cum laude in accounting in 1965 and an MBA in 1967. He is married with two adult children.

May, 2008




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX